Methods of Evaluating the Efficiency of CRISPR/Cas Genome Editing
- Authors: Lomov N.A.1,2, Viushkov V.S.1,2, Petrenko A.P.1, Syrkina M.S.1,2, Rubtsov M.A.1,2,3
-
Affiliations:
- Moscow State University
- LIA LFR20 Laboratoire Franco-Russe de Recherches en Oncologie, Moscow State University
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 53, No 6 (2019)
- Pages: 862-875
- Section: Reviews
- URL: https://journal-vniispk.ru/0026-8933/article/view/164113
- DOI: https://doi.org/10.1134/S0026893319060116
- ID: 164113
Cite item
Abstract
The CRISPR/Cas system is currently widely used for genome editing. The procedure of genome editing includes two necessary steps: (i) searching for the most effective guide RNA, and (ii) analyzing clones for presence of the desired mutation. This review presents the methods used to assess the efficiency of the CRISPR/Cas system and to confirm mutation in the target locus and discusses their advantages and disadvantages. It aims to provide information that could help researchers to choose a technique most appropriate for their specific tasks and available resources.
About the authors
N. A. Lomov
Moscow State University; LIA LFR20 Laboratoire Franco-Russe de Recherches en Oncologie, Moscow State University
Author for correspondence.
Email: lomov13@gmail.com
Russian Federation, Moscow, 119991; Moscow, 119991
V. S. Viushkov
Moscow State University; LIA LFR20 Laboratoire Franco-Russe de Recherches en Oncologie, Moscow State University
Author for correspondence.
Email: vyushkov22@gmail.com
Russian Federation, Moscow, 119991; Moscow, 119991
A. P. Petrenko
Moscow State University
Email: ma_rubtsov@mail.ru
Russian Federation, Moscow, 119991
M. S. Syrkina
Moscow State University; LIA LFR20 Laboratoire Franco-Russe de Recherches en Oncologie, Moscow State University
Email: ma_rubtsov@mail.ru
Russian Federation, Moscow, 119991; Moscow, 119991
M. A. Rubtsov
Moscow State University; LIA LFR20 Laboratoire Franco-Russe de Recherches en Oncologie, Moscow State University; Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: ma_rubtsov@mail.ru
Russian Federation, Moscow, 119991; Moscow, 119991; Moscow, 119991
Supplementary files
